TEST FOR CORONAVIRUS – WHAT DOES IT REALLY MEANS FOR THE PATIENT?

Authors

DOI:

https://doi.org/10.11603/1681-2727.2020.2.11287

Keywords:

coronavirus, SARS-Cov-2, nCov19, detection, tests, PCR, ELISA, IgM, IgG, IgA

Abstract

Testing for COVID has become one of the common day activities during pandemic days, often like a visit to dentist or family doctor. However, there are many types of tests with different principles, sensitivities, specificities, and diagnostic windows. And since the COVID disease has a great impact on our social life, changing our behavior, social contacts, and attitude, the incorrect treatment of «test for COVID» can have deteriorating results. The «COVID test» is seldom interpreted correctly due to multiple technologies, ways of testing, sensitivities and even influence of social media. Here we in a simple form summarize the most common detection methods with their peculiarities in the form of Q&A which typical patients can have. We discuss RT-qPCR, POC express tests, ELISA testing for IgG, IgM antibodies, as well as present our data regarding the longevity of blood antibody titers against coronaviral antigens.

Author Biographies

R. Yu. Hrytsko, Danylo Halytsky Lviv National Medical University

DS in State Management, MD, Associate Professor of the Department of Infectious Diseases, Danylo Halytsky Lviv National Medical University

H. I. Bila, Danylo Halytsky Lviv National Medical University

Senior research assistant, Department of Histology, Cytology and Embriology, Danylo Halytsky Lviv National Medical University; Researcher of Horizon2020 project “NeutroCure” Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation

R. O. Bilyy, Danylo Halytsky Lviv National Medical University

DS (Biology), Professor, Professor of the Department of Histology, Cytology and Embriology Danylo Halytsky Lviv National Medical University; PI of Horizon2020 project “PANG” Pathogenes and Graphene

References

Bilyy, R., Paryzhak, S., Turcheniuk, K., Dumych, T., Barras, A., Boukherroub, R., … Szunerits, S. (2019). Aluminum oxide nanowires as safe and effective adjuvants for next-generation vaccines. Materials Today, 22, 58-66. DOI:10.1016/j.mattod.2018.10.034

Narasaraju, T., Tang, B.M., Herrmann, M., Muller, S., Chow, V.T.K., & Radic, M. (2020). Neutrophilia and NETopathy as key pathologic drivers of progressive lung impairment in patients with COVID-19. Frontiers in Pharmacology, 11. DOI:10.3389/fphar.2020.00870

Backer, J.A., Klinkenberg, D., & Wallinga, J. (2020). Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020. Eurosurveillance, 25 (5). DOI:10.2807/1560-7917.ES.2020.25.5.2000062

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., … Peng, Z. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus–infected pneumonia in Wuhan, China. JAMA, 323 (11), 1061. DOI:10.1001/jama.2020.1585

Lippi, G., Simundic, A.-M., & Plebani, M. (2020). Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). Clinical Chemistry and Laboratory Medicine (CCLM), 58 (7), 1070-1076. DOI:10.1515/cclm-2020-0285

Young, B.E., Ong, S.W.X., Kalimuddin, S., Low, J.G., Tan, S.Y., Loh, J., … Lye, D.C. (2020). Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA, 323 (15), 1488. DOI:10.1001/jama.2020.3204

Long, Q.-X., Liu, B.-Z., Deng, H.-J., Wu, G.-C., Deng, K., Chen, Y.-K., … Huang, A.-L. (2020). Antibody responses to SARS-CoV-2 in patients with COVID-19. Nature Medicine. DOI:10.1038/s41591-020-0897-1

Xiao, A.T., Gao, C., & Zhang, S. (2020). Profile of specific antibodies to SARS-CoV-2: The first report. Journal of Infection, 81 (1), 147-178. DOI:10.1016/j.jinf.2020.03.012

Yu, H., Sun, B., Fang, Z., Zhao, J., Liu, X., Li, Y., … Zhong, N. (2020). Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients. European Respiratory Journal, 2001526. DOI:10.1183/13993003.01526-2020

Huang, A.T., Garcia-Carreras, B., Hitchings, M.D.T., Yang, B., Katzelnick, L., Rattigan, S.M., … Cummings, D.A.T. (2020). A sys­tematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease. Med.Rxiv., 2020.04.14.20065771. DOI:10.1101/2020.04.14.20065771

Published

2020-08-11

How to Cite

Hrytsko, R. Y., Bila, H. I., & Bilyy, R. O. (2020). TEST FOR CORONAVIRUS – WHAT DOES IT REALLY MEANS FOR THE PATIENT?. Infectious Diseases – Infektsiyni Khvoroby, (2), 65–72. https://doi.org/10.11603/1681-2727.2020.2.11287

Issue

Section

Reviews and lectures